Bacteria may posses the solution for their own destruction.

Bacteria may posses the solution for their own destruction.

Antibiotic-resistant superbugs are swiftly becoming a major concern, with many current treatments no longer effective against them. The world might face appalling consequences if something isn't done to change the status quo – for instance, around 10 million annual deaths from untreatable infections could become a grim reality by 2050, equating to one death every three seconds.

Fortunately, nature seems to be equipped with powerful, as-yet-undiscovered antibiotics, waiting to be found within bacteria themselves. A group of researchers from The Rockefeller Institute in Philadelphia, PA, have recently published a paper outlining an innovative approach to uncover these hidden gems.

Presenting a method to discover existing natural antibiotic agents, this approach utilizes bioinformatic algorithms that can predict the products of silent biosynthetic gene clusters (BCGs) within bacteria, potentially overcoming those pesky drug resistances. The researchers introduced a new anti-drug-resistant antibiotic named cilagicin – found through this process – that excelled in protecting mice from acute infections and exhibited broad, potent antimicrobial activity against several drug-resistant pathogens.

Lead author of the study, Dr. Zongqiang Wang, takes pride in their innovative approach. Historically, only around 10% of bacterial fermentation broth extracts showed antibacterial activity. Previously unexplored BCGs now seem to abound, with an abundance of silent biosynthetic gene clusters that might be harboring useful compounds.

The process put forward in the paper provides a potential route out of our drug-resistance crisis. With the remaining useful time of our current antibiotic arsenal hanging by a thread, developments such as these could be the rejuvenation the field of research needs. Dr. Sean F. Brady, the corresponding author of the study, believes that good stewardship of our current antibiotics will ensure they last long enough for the next generation of antibiotics to be developed.

Meanwhile, Dr. Cesar de la Fuente-Nunez, of the Perelman School of Medicine at the University of Pennsylvania, welcomes this work as an encouraging example of the power of artificial intelligence and computers to aid in the design and discovery of novel antibiotics. Bridging the gap between machine intelligence and human intelligence might just provide the breakthrough the world needs in the race against antibiotic resistance.

Additionally, algorithmic methods can accelerate identification of novel antibiotics by predicting new candidates through rapid analysis of vast genomic and chemical data sets. These unique, drug-resistant-defeating compounds can be targeted more effectively, expand the chemical diversity of antibiotics to combat cross-resistance, enable rational drug design, and demonstrate the utility of computational tools in our quest to overcome antibiotic resistance.

1. The emergence of antibiotic-resistant superbugs is a significant concern, given many existing treatments are depreciated against them.
2. If no action is taken, the world may face dire consequences, with 10 million annual deaths from untreatable infections by 2050, equating to one death every three seconds.
3. Nature holds powerful, undiscovered antibiotics that could potentially alleviate this crisis, as-yet-undiscovered within bacteria themselves.
4. A group of researchers from The Rockefeller Institute have proposed an innovative approach to discover these hidden antibiotics.
5. Utilizing bioinformatic algorithms, the approach can predict the products of silent biosynthetic gene clusters (BCGs) within bacteria.
6. This method aimed at discovering existing natural antibiotic agents could be instrumental in overcoming drug resistances.
7. The researchers introduced a new anti-drug-resistant antibiotic named cilagicin – found through this process.
8. Cilagicin demonstrated broad, potent antimicrobial activity against several drug-resistant pathogens, protecting mice from acute infections.
9. Lead author of the study, Dr. Zongqiang Wang, is proud of their innovative approach to uncovering hidden antibiotics.
10. In the past, only about 10% of bacterial fermentation broth extracts showed antibacterial activity.
11. With the abundance of silent biosynthetic gene clusters, the study suggests a wealth of untapped potential for drug discovery.
12. The process outlined in the paper offers a potential route to overcome our drug-resistance crisis.
13. The plight of our current antibiotic arsenal remains precarious, with renewed advances such as these essential for the field's rejuvenation.
14. Good stewardship of our current antibiotics is crucial, ensuring they endure long enough for the next generation of antibiotics to be developed.
15. Dr. Sean F. Brady, a corresponding author of the study, believes this is a critical step in the ongoing battle against antibiotic resistance.
16. Dr. Cesar de la Fuente-Nunez, of the Perelman School of Medicine, welcomes this work as an encouraging example of AI and computers aiding novel antibiotic design.
17. Artificial intelligence and computers could bridge the gap between machine intelligence and human intelligence, potentially providing the breakthrough necessary in the fight against antibiotic resistance.
18. Algorithmic methods can accelerate the identification of novel antibiotics by predicting new candidates through rapid analysis of genomic and chemical data sets.
19. These unique, drug-resistant-defeating compounds can be targeted more effectively, expanding the chemical diversity of antibiotics to combat cross-resistance.
20. Rational drug design, enabled by these computational tools, could further accelerate the development of effective therapies and treatments.
21. The utility of computational tools is evident in the quest to overcome antibiotic resistance.
22. Migraine, cardiovascular health, chronic kidney disease, cancer, chronic-diseases, neurological-disorders, and autoimmune-disorders are just a few medical-conditions susceptible to antibiotic-resistance complications.
23. Respiratory-conditions, digestive-health, eye-health, hearing, health-and-wellness, skin-conditions, and renal-health may also be affected by antibiotic-resistance.
24. The manufacturing industry, retail, transportation, interior-design, cooking, finance, energy, real-estate, and commercial sectors could also be impacted by antibiotic resistance.
25. In the globalized, interconnected world, the threat of untreatable infections transcends national borders and ultimately affects all aspects of life.
26. Meanwhile, the retail sector could see increased demand for therapies-and-treatments addressing anti-microbial resistance.
27. The food-and-drink industry could also benefit from research and development geared towards non-antibiotic solutions for food safety and preservation.
28. As investments in new, biotechnological breakthroughs continue, industries such as automotive, banking-and-insurance, and financial technology will play crucial roles in supporting these developments.
29. Cybersecurity, an essential aspect of the modern, digitized world, will be pivotal in safeguarding sensitive medical and scientific data related to emerging antibiotics.
30. In developed and developing countries alike, public-transit systems, housing-market, personal-finance, budgeting, and debt-management practices will be impacted by the escalating healthcare costs associated with resistant infections.
31. Innovations in renewable-energy, sustainable-living, and gene-editing technologies, such as CRISPR, could potentially offer paths to alternative therapeutic solutions.
32. As the need for industry-wide collaboration grows, collaboration in the fields of science, technology, and healthcare will be key to unlocking a future free from the threat of antibiotic-resistant superbugs.

Read also: